2m 2m 2m 2m 2m 2m 2m
Targeted Med Pha (TRGM)
OTC
$0.000007+$0.000006 (+600.00%)
Price as of May 14, 2026- $211.00Market Cap
- 600.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Targeted Med Pha (TRGM)
$0.000007+$0.000006 (+600.00%)
TRGM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.000006 (+600.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 2,900 | ||
30-Day Average Volume | 2,000 | ||
1-Week Change | 600.00% | ||
1-Month Change | -93.00% | ||
1-Year Change | 600.00% | ||
3-Year Change | -93.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.2M | ||
Total Assets | $2.4M | ||
Market Cap | $211.00 | ||
Enterprise Value | $5.2M | ||
Period: QTR TTM FY | |||
Revenue | $1.3M | ||
Net Income | -$581,473.00 | ||
Free Cash Flow | $76,543.00 | ||
EBIT | -$343,467.00 | ||
EBITDA | -$329,900.00 | ||
Net Working Capital | -$13.8M | ||
EPS | -$0.02 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 4 | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | 0 | ||
Price/Operating Cash Flow | 0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||